BCM
BEAT

Bridgeway Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bridgeway Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,900
Closed -$403K – 1451
2019
Q3 		$403K Hold
9,900
– – 0.01% 1030
2019
Q2 		$477K Hold
9,900
– – 0.01% 990
2019
Q1 		$620K Sell
9,900
-1,800
-15% -$124K 0.01% 957
2018
Q4 		$699K Hold
11,700
– – 0.01% 887
2018
Q3 		$754K Sell
11,700
-6,900
-37% -$385K 0.01% 1011
2018
Q2 		$837K Sell
18,600
-1,900
-9% -$75.8K 0.01% 938
2018
Q1 		$637K Buy
+20,500
New +$674K 0.01% 1015
2017
Q4 		– Sell
-6,450
Closed -$213K – 1505
2017
Q3 		$213K Sell
6,450
-200
-3% -$6.93K ﹤0.01% 1271
2017
Q2 		$222K Sell
6,650
-450
-6% -$13.4K ﹤0.01% 1270
2017
Q1 		$206K Sell
7,100
-46,756
-87% -$1.16M ﹤0.01% 1274
2016
Q4 		$1.2M Sell
53,856
-73,844
-58% -$1.44M 0.02% 743
2016
Q3 		$2.37M Sell
127,700
-45,200
-26% -$852K 0.04% 473
2016
Q2 		$2.82M Sell
172,900
-10,500
-6% -$154K 0.04% 382
2016
Q1 		$2.14M Sell
183,400
-10,000
-5% -$112K 0.04% 495
2015
Q4 		$2.26M Sell
193,400
-17,500
-8% -$221K 0.04% 462
2015
Q3 		$2.58M Buy
210,900
+33,000
+19% +$421K 0.05% 399
2015
Q2 		$1.68M Hold
177,900
– – 0.03% 580
2015
Q1 		$1.57M Hold
177,900
– – 0.03% 611
2014
Q4 		$1.78M Sell
177,900
-109,579
-38% -$940K 0.04% 558
2014
Q3 		$1.93M Sell
287,479
-181,000
-39% -$1.27M 0.05% 504
2014
Q2 		$3.36M Buy
468,479
+3,300
+0.7% +$26.3K 0.09% 303
2014
Q1 		$4.69M Buy
465,179
+5,000
+1% +$46K 0.13% 183
2013
Q4 		$3.65M Hold
460,179
– – 0.11% 209
2013
Q3 		$4.56M Buy
460,179
+169,100
+58% +$1.33M 0.16% 122
2013
Q2 		$1.72M Buy
+291,079
New +$979K 0.07% 405

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bridgeway Capital Management's BEAT Position: Q4 2019 in Review

Bridgeway Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 9,900 shares — an estimated $403K sold.

Bridgeway Capital Management first reported a position in BEAT in Q2 2013 and held it in 25 quarters. The position peaked at $4.69M in Q1 2014. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Bridgeway Capital Management reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • Bridgeway Capital Management sold 9,900 BioTelemetry, Inc. shares in Q4 2019, an estimated $403K.
  • Bridgeway Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 25 quarters.
  • Bridgeway Capital Management's BioTelemetry, Inc. position peaked at $4.69M in Q1 2014.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Bridgeway Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.